Home・Lista de Ações・ADMA Biologics Inc

ADMA Biologics Inc

Fechado

SetorSaúde

8.72 -0.46

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

8.48

Máximo

8.77

Indicadores-chave
By Trading Economics
Rendimento	-4.1M 45M
Vendas	-25M 114M
P/E Médio do Setor	12.471 64.641
EPS	0.17
Margem de lucro	39.59
Funcionários	640
EBITDA	-4.2M 61M

Recomendações
By TipRanks
Recomendações	Compra Forte
Previsão para 12 meses	+120.17% upside

Dividendos
By Acuity
Próximos Ganhos	5 de ago. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	-430M 2B
Abertura anterior	9.18
Fecho anterior	8.72

Sentimento de Notícias

By Acuity

74%

26%

297 / 340 Ranking em Healthcare

ADMA Biologics Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

28 de jul. de 2026, 20:06 UTC

News

ADMA Biologics Inc. is rising amid broader biotechnology sector strength, despite ongoing legal challenges. The stock has shown steady gains since Monday's close.

27 de jul. de 2026, 19:41 UTC

ADMA Biologics Inc shares are higher today, continuing a strong performance since Friday. No specific news was identified to explain the gains.

24 de jul. de 2026, 19:26 UTC

News

ADMA Biologics shares are lower amid a securities fraud lawsuit alleging inflated revenue growth and related party transactions, impacting investor sentiment.

22 de jul. de 2026, 18:36 UTC

News

ADMA Biologics shares are lower as a class action lawsuit targets investors, alleging false statements about business practices and internal controls.

21 de jul. de 2026, 19:36 UTC

News

ADMA Biologics Inc faces a class action lawsuit alleging securities fraud, contributing to its decline since Monday's close. Shares briefly rebounded earlier in the session.

20 de jul. de 2026, 19:46 UTC

ADMA Biologics Inc shares are higher during Monday's session, despite fluctuations and no specific news to explain the price action since Friday's close.

Comparação entre Pares

Variação de preço

ADMA Biologics Inc Previsão

Preço-alvo

By TipRanks

120.17% parte superior

Previsão para 12 meses

Média 18.67 USD 120.17%

Máximo 21 USD

Mínimo 17 USD

Com base em 3 analistas de Wall Street que oferecem metas de preço de 12 meses para ADMA Biologics Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

3 ratings

Comprar

Manter

Vender

Com base em 3 analistas que deram avaliações de ações para ADMA Biologics Inc - Dist nos últimos 3 meses.

Sentimento

By Acuity

297 / 340 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre ADMA Biologics Inc

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.